# A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

> **NCT04277910** · PHASE1 · COMPLETED · sponsor: **Xi'an Biocare Pharma Ltd.** · enrollment: 88 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MT2004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04277910
- **Lead sponsor:** Xi'an Biocare Pharma Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-09
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04277910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04277910, "A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04277910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*